**Authors' contribution**

XF developed the general idea and drafted the manuscript with CJ; YLQ and DYX searched the reference, HK sort the clinical trials data, PTT and ZS participated in drafting process and double check the data; LFF drew the figure; GM proofread the manuscript and ensure the general quality.

**Author details**

Hong Kong, Hong Kong, China

Kun Huang<sup>5</sup>

Jie Chen1,2†, Liqiong Yang3†, Yuxi Duan3†, Tinging Pu3

*What Are the New Challenges of the Current Cancer Biomarkers?*

*DOI: http://dx.doi.org/10.5772/intechopen.89976*

\*

3 School of Pharmacy, Chengdu Medical College, Sichuan, China

5 Department of Software, Chengdu TME Co., Ltd, China

\*Address all correspondence to: xufan@cmc.edu.cn

† These authors contributed equally.

provided the original work is properly cited.

**139**

6 Neuro Occupational Activity Centre Novo Mesto, Slovenia

4 Art College, Southwest Minzu University, Chengdu, Sichuan, China

7 Department of Public Health, Chengdu Medical College, Sichuan, China

© 2019 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium,

1 School of Chinese Medicine, Li Ka Shing Faculty of Medicine, The University of

2 Department of Orthopedics, Shanghai Institute of Traumatology and Orthopedics, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China

, Greg Mirt6 and Fan Xu<sup>7</sup>

, Sha Zheng<sup>3</sup>

, Fangfang Liu<sup>4</sup>

,
